Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid [NA]
This document reports that Washington University School of Medicine is implementing a randomized controlled trial to evaluate an expanded we…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma [Phase 3]
A Phase 3 trial evaluating aspirin versus rivaroxaban for thromboprophylaxis in patients with multiple myeloma to prevent venous thromboembo…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Mosaic Trial for Stem Cell Transplant Recipients [NA]
This clinical trial update indicates the Mosaic trial for stem cell transplant recipients is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients? [Phase 2]
Phase 2 trial update comparing CAR-T cell therapy versus autologous stem cell transplant for newly diagnosed multiple myeloma; the study is …
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible [NA]
A clinical trial from Xuzhou Medical University is evaluating anti-BCMA CAR-T therapy in newly diagnosed multiple myeloma patients who are t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
This clinical trial update describes a study comparing quality of life and treatment outcomes in relapsed/refractory multiple myeloma patien…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM [Phase 2]
The MMRC Horizon One adaptive platform trial evaluating therapies for relapsed or refractory multiple myeloma is in Phase 2 and currently re…
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: MYeloma Resistance And Clonal Evolution
A Nantes University Hospital-sponsored clinical trial called "MYeloma Resistance And Clonal Evolution" is currently recruiting. The study fo…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) [NA]
A Washington University School of Medicine trial (WU-PE-CGS) is currently recruiting participants for cholangiocarcinoma, multiple myeloma, …
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties [NA]
A music therapy study at Memorial Sloan Kettering Cancer Center is evaluating whether music-based interventions can help cognitive difficult…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma [NA]
A clinical trial is evaluating low-dose radiotherapy to relieve bone metastasis–related pain in patients with multiple myeloma and is curren…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors [EARLY_Phase 1]
This is an early-phase study evaluating allogeneic CD19/BCMA CAR-T cells for relapsed/refractory B-cell malignancies, currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention [NA]
This is a clinical trial evaluating a tele-delivered lifestyle intervention for veterans with blood cancers, and it is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Study of MCARH109 and MCARH125 in People With Multiple Myeloma [Phase 1]
A Phase 1 clinical trial update on MCARH109 and MCARH125 in people with multiple myeloma, including refractory and relapsed disease, current…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Horizon Two Adaptive Platform Study in High Risk Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 adaptive platform trial Horizon Two for high-risk newly diagnosed multiple myeloma is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
This clinical trial update describes the use of the PET imaging agent 18F-fluorothymidine (18F-FLT) in cancer patients to assess tumor proli…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Lenalidomide Maintenance in Plasma Cell Myeloma [Phase 2]
A Phase 2 clinical trial of lenalidomide as maintenance therapy for plasma cell myeloma is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: DARA RVD For High Risk SMM [Phase 2]
A Phase 2 trial investigates adding daratumumab to the RVD regimen for high-risk Smoldering multiple myeloma and multiple myeloma; the study…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy [Phase 2]
Phase 2 clinical trial for patients with multiple myeloma who do not qualify for TT4 and TT5 protocols due to prior therapy; the study is cu…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission [Phase 2]
Phase 2 trial by the University of Arkansas for high-risk multiple myeloma evaluating accelerating and sustaining complete remission is curr…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma [Phase 3]
This is an update on a Phase III trial (Total Therapy 4B) for low-risk multiple myeloma (NCT00734877) led by the University of Arkansas; the…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Multiple Myeloma Molecular Monitoring Study
Horizon Health Network reports that its study on molecular monitoring for multiple myeloma is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)
This document reports on a prospective, non-interventional observational study evaluating isatuximab in patients with relapsed and/or refrac…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients [Phase 3]
Phase 3 trial evaluating SG301 in combination with pomalidomide and dexamethasone vs placebo with pomalidomide and dexamethasone in relapsed…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions
A clinical trial update describes evaluating 68Ga-Pentixafor PET/MR for detecting lesions in non-Hodgkin lymphoma and multiple myeloma; the …